Acarbose Cardiovascular Evaluation Trial

Bio2RDF identifier

NCT00829660

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00829660

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00829660

acronym [clinicaltrials_vocabulary:acronym]

ACE

http://www.w3.org/2001/XMLSchema#string

anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]

7,500

http://www.w3.org/2001/XMLSchema#integer

arm group [clinicaltrials_vocabulary:arm-group]

NCT00829660 arm group 77070c4301fd80b8ed0b70bd7a876b09 [clinicaltrials_resource:NCT00829660/arm-group/77070c4301fd80b8ed0b70bd7a876b09]

NCT00829660 arm group 86a641a0895e81b92689fc1ada3e3b1e [clinicaltrials_resource:NCT00829660/arm-group/86a641a0895e81b92689fc1ada3e3b1e]

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:245b0106e3be1922b847a6799a540c10

brief summary [clinicaltrials_vocabulary:brief-summary]

The purpose of this stu ...... ) in this patient population.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Acarbose Cardiovascular Evaluation Trial

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Occurrence of any of the following; Cardiovascular death, Non-fatal MI, Non-fatal stroke Follow-up for approximately 4 years until 904 adjudicated Primary Outcome Measures have been recorded [clinicaltrials_resource:29da1ea9fa3ab51c45c3dc9476d72feb]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Occurrence of any of the following; Cardiovascular death, Non-fatal MI, Non-fatal stroke Follow-up for approximately 4 years until 904 adjudicated Primary Outcome Measures have been recorded [clinicaltrials_resource:69633efde1edf00b92c4aa62d086aa85]

Occurrence of any of the following; Cardiovascular death, Non-fatal MI, Non-fatal stroke Follow-up for approximately 4 years until 904 adjudicated Primary Outcome Measures have been recorded [clinicaltrials_resource:77e27f256d66fe96faadaa4897b7208f]

Occurrence of any of the following; Cardiovascular death, Non-fatal MI, Non-fatal stroke Follow-up for approximately 4 years until 904 adjudicated Primary Outcome Measures have been recorded [clinicaltrials_resource:7d4252ef426ebe5a1eb06e8c4cac3cd9]

Occurrence of any of the following; Cardiovascular death, Non-fatal MI, Non-fatal stroke Follow-up for approximately 4 years until 904 adjudicated Primary Outcome Measures have been recorded [clinicaltrials_resource:84841f18ea589a5df4e0dece62a558bd]

Occurrence of any of the following; Cardiovascular death, Non-fatal MI, Non-fatal stroke Follow-up for approximately 4 years until 904 adjudicated Primary Outcome Measures have been recorded [clinicaltrials_resource:9e490bfeb9aa7225654deb8a20635637]

Occurrence of any of the following; Cardiovascular death, Non-fatal MI, Non-fatal stroke Follow-up for approximately 4 years until 904 adjudicated Primary Outcome Measures have been recorded [clinicaltrials_resource:d62e717d07ec66d4e317212e4d23fbeb]

collaborator [clinicaltrials_vocabulary:collaborator]

University of Oxford [clinicaltrials_resource:4fd6f7d59a501f9b8bac2be37914c43e]

completion date [clinicaltrials_vocabulary:completion-date]

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

detailed description [clinicaltrials_vocabulary:detailed-description]

A 4-year, multi-centre, ...... ired glucose tolerance.

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00829660 [clinicaltrials_resource:07dc8ecb77f9cc30b0143109bcd389f8]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2009-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

No

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

Matching Placebo [clinicaltrials_resource:381fd85892f1d5636bb4858b0aaf1bf2]

Acarbose [clinicaltrials_resource:437ec0c907723b86b1159897a54bf68b]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Acarbose [clinicaltrials_resource:86a641a0895e81b92689fc1ada3e3b1e]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

No

http://www.w3.org/2001/XMLSchema#string

keyword [clinicaltrials_vocabulary:keyword]

Acarbose

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2011-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

University of Oxford [clinicaltrials_resource:4fd6f7d59a501f9b8bac2be37914c43e]

link [clinicaltrials_vocabulary:link]

Diabetes Trials Unit, International Co-ordinating Centre for the ACE Trial [clinicaltrials_resource:a1c9a70c19241f3ba540ea09f3cc769e]

location [clinicaltrials_vocabulary:location]

Aerospace Central Hospital [clinicaltrials_resource:bbb565c1310b2545825b42f638d0d260]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00829660

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

2

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

A Phase IV Trial to Determine ...... ve Impaired Glucose Tolerance.

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

11,232

http://www.w3.org/2001/XMLSchema#integer

overall contact [clinicaltrials_vocabulary:overall-contact]

Professor Rury R Holman, FRCP [clinicaltrials_resource:7943f06f7cbaf9e596dbb64c203d35fd]

overall official [clinicaltrials_vocabulary:overall-official]

Professor Rury R Holman, FRCP [clinicaltrials_resource:695994b977b134b1c7ab3415456b5199]

overall status [clinicaltrials_vocabulary:overall-status]

Recruiting [clinicaltrials_resource:5231dee7156b84b0d1854de1a18dd169]

oversight [clinicaltrials_vocabulary:oversight]

China: Food and Drug Administration [clinicaltrials_resource:0656e9fba8f4744bb2eb0165736c72dd]

phase [clinicaltrials_vocabulary:phase]

Phase 4 [clinicaltrials_resource:ec41833bc88cd90619c4d85c549688bd]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

responsible party [clinicaltrials_vocabulary:responsible-party]

Professor Rury Holman, Diabetes Trials Unit, University of Oxford [clinicaltrials_resource:674eaf36c9e8355f4d9ab08f4b611611]

secondary id [clinicaltrials_vocabulary:secondary-id]

ISRCTN91899513

http://www.w3.org/2001/XMLSchema#string

source [clinicaltrials_vocabulary:source]

University of Oxford [clinicaltrials_resource:4fd6f7d59a501f9b8bac2be37914c43e]

start date [clinicaltrials_vocabulary:start-date]

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00829660 study design [clinicaltrials_resource:f81546fa7199a124a2a386dc51f5ebee]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00829660

verification date [clinicaltrials_vocabulary:verification-date]

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00829660

http://www.w3.org/2001/XMLSchema#string